News

NEW Very Large Sleep Apnea Study

Fullpower-AI October 22, 2024

I am excited to share groundbreaking research on Obstructive Sleep Apnea (OSA) detection and prevalence, presented at the Seville Sleep Conference! Our Sleeptracker.ai platform, in collaboration with Stanford Sleep Medicine and UCSF, has conducted one of the most extensive studies in this field.



Key Findings:
• Analyzed 17,173,525 nights of sleep data from 52,637 participants
• Revealed limitations of single-night OSA assessments
• Discovered higher OSA prevalence in women ≥50 years compared to younger women

Why This Matters:

Continuous Monitoring: Our Sleeptracker.ai enables non-invasive, nightly sleep tracking, providing a more comprehensive view of sleep health.

Improved Detection: Maximum AHI across 3 nights shows high sensitivity (≥95%) for detecting moderate to severe OSA.

Gender and Age Insights: Women over 50 show a greater increase in OSA odds compared to men, potentially linked to menopausal factors.

Personalized Care: Identifying OSA severity fluctuations over time allows for more tailored treatment approaches.

Early detection and management of OSA can significantly improve quality of life and reduce associated health risks. Our research demonstrates the power of continuous sleep monitoring in revolutionizing sleep health assessment and care.

We are proud of our team and grateful for our collaborators in pushing the boundaries of sleep science! https://sleeptracker.com/

Fullpower-AI

About Fullpower-AI®
Fullpower-AI® is the developer of the Sleeptracker-AI Platform. Fullpower-AI® is a leading science and technology company specializing in real-time AI deep-learning biosensing. Our edge-to-cloud platform, backed by 135+ patents and ISO 27001 certification, serves diverse industries, including sleep technology (Sleeptracker.ai), life sciences, longevity, and healthcare across 140+ countries. We offer flexible engagement models through CRO services, IP licensing, and PaaS solutions, empowering organizations to advance sleep science, healthcare outcomes, and wellness. Stanford Sleep Medicine and UCSF vet our platform.